# FDA Inspection 1112627 - Boehringer Ingelheim Pharmaceuticals, Inc. - December 12, 2019

Source: https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharmaceuticals-inc/3cec078a-63a0-4054-aba3-a7b39a8fad4e
Source feed: FDA_Inspections

> FDA Inspection 1112627 for Boehringer Ingelheim Pharmaceuticals, Inc. on December 12, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1112627
- Company Name: Boehringer Ingelheim Pharmaceuticals, Inc.
- Inspection Date: 2019-12-12
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1281125 - 2025-09-11](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharmaceuticals-inc/9c62d459-d5fc-4614-8d41-987968509962)
- [FDA Inspection 1281125 - 2025-09-11](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharmaceuticals-inc/6d9e76cb-66db-4338-89fe-f8f4ab53bb15)
- [FDA Inspection 1219707 - 2023-09-22](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharmaceuticals-inc/119b61c4-4cb0-4efb-bddf-d360ea05cf99)
- [FDA Inspection 1073537 - 2018-12-06](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharmaceuticals-inc/e71d8ac5-5980-4791-92de-944874b88e24)
- [FDA Inspection 1004536 - 2017-02-28](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharmaceuticals-inc/348dac8e-c7ba-4f7a-aacc-cec40017cc2a)

Company: https://www.keypedia.com/companies/boehringer-ingelheim-pharmaceuticals-inc/437c28a1-054f-4c22-9dba-fd40af58a7be

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c